Cohen JD - Search Results

1

The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.

Cohen G, Courvoisier N, Cohen JD, Zaltni S, Sany J, Combe B. Cohen G, et al. Among authors: cohen jd. Clin Exp Rheumatol. 2005 Nov-Dec;23(6):795-800. Clin Exp Rheumatol. 2005. PMID: 16396697

2

Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis.

Fabre S, Dupuy AM, Dossat N, Guisset C, Cohen JD, Cristol JP, Daures JP, Jorgensen C. Fabre S, et al. Among authors: cohen jd. Clin Exp Immunol. 2008 Aug;153(2):188-95. doi: 10.1111/j.1365-2249.2008.03691.x. Epub 2008 Jun 18. Clin Exp Immunol. 2008. PMID: 18549443 Free PMC article.

3

Secondary addition of methotrexate to partial responders to etanercept alone is effective in severe rheumatoid arthritis.

Cohen JD, Zaltni S, Kaiser MJ, Bozonnat MC, Jorgensen C, Daurès JP, Sany J. Cohen JD, et al. Ann Rheum Dis. 2004 Feb;63(2):209-10. doi: 10.1136/ard.2003.013532. Ann Rheum Dis. 2004. PMID: 14722213 Free PMC article. No abstract available.

4

Protein biochip array technology to monitor rituximab in rheumatoid arthritis.

Fabre S, Guisset C, Tatem L, Dossat N, Dupuy AM, Cohen JD, Cristol JP, Daures JP, Jorgensen C. Fabre S, et al. Among authors: cohen jd. Clin Exp Immunol. 2009 Mar;155(3):395-402. doi: 10.1111/j.1365-2249.2008.03804.x. Clin Exp Immunol. 2009. PMID: 19220830 Free PMC article.

5

Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.

Cohen JD, Bournerias I, Buffard V, Paufler A, Chevalier X, Bagot M, Claudepierre P. Cohen JD, et al. J Rheumatol. 2007 Feb;34(2):380-5. Epub 2006 Oct 1. J Rheumatol. 2007. PMID: 17013997

6

Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies.

Cohen JD, Cunin P, Farrenq V, Oniankitan O, Carton L, Chevalier X, Claudepierre P. Cohen JD, et al. J Rheumatol. 2006 Jan;33(1):79-81. J Rheumatol. 2006. PMID: 16395754

7

[Anti-TNF alpha in the treatment of psoriatic arthritis].

Claudepierre P, Wendling D, Cohen JD. Claudepierre P, et al. Among authors: cohen jd. Presse Med. 2006 Apr;35(4 Pt 2):647-55. doi: 10.1016/s0755-4982(06)74658-9. Presse Med. 2006. PMID: 16614610 Review. French.

8

Ankylosing spondylitis refractory to tumor necrosis factor blockade responds to tocilizumab.

Cohen JD, Ferreira R, Jorgensen C. Cohen JD, et al. J Rheumatol. 2011 Jul;38(7):1527. doi: 10.3899/jrheum.110265. J Rheumatol. 2011. PMID: 21724733 No abstract available.

9

Sarcoidosis induced by tocilizumab: a paradoxical event?

Nutz A, Pernet C, Combe B, Cohen JD. Nutz A, et al. Among authors: cohen jd. J Rheumatol. 2013 Oct;40(10):1773-4. doi: 10.3899/jrheum.130278. J Rheumatol. 2013. PMID: 24085760 No abstract available.

10

Medico-economic evaluation of infliximab in rheumatoid arthritis--prospective French study of a cohort of 635 patients monitored for two years.

Sany J, Cohen JD, Combescure C, Bozonnat MC, Roch-Bras F, Lafon G, Daurès JP. Sany J, et al. Among authors: cohen jd. Rheumatology (Oxford). 2009 Oct;48(10):1236-41. doi: 10.1093/rheumatology/kep198. Epub 2009 Jul 20. Rheumatology (Oxford). 2009. PMID: 19620209

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results